Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Inovio's Latest COVID Vaccine Results: Too Little, Too Late?

TheMotleyFool

0 0

Inovio's Latest COVID Vaccine Results: Too Little, Too Late?

Inovio Pharmaceuticals (NASDAQ: INO) recently reported encouraging results from a phase 2 study of its COVID-19 vaccine candidate INO-4800. However, the company lags well behind the current leaders in the COVID-19 vaccine market. In this Motley Fool Live video recorded on May 12, Motley Fool contributors Keith Speights and Brian Orelli discuss Inovio's latest clinical results.

Source Fool.com

Like: 0

INO

Share